(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1352880 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of COL6A1 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO RGD:1558231 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COL6A1 mRNA CTD PMID:36331819 (S)-nicotine multiple interactions ISO RGD:1558231 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1,2-dimethylhydrazine multiple interactions ISO RGD:1558231 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of COL6A1 mRNA CTD PMID:22206623 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO RGD:1558231 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:1558231 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of COL6A1 mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression ISO RGD:1558231 6480464 Ethinyl Estradiol results in increased expression of COL6A1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1558231 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COL6A1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1558231 6480464 Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of COL6A1 mRNA] CTD PMID:16977382 17beta-estradiol multiple interactions ISO RGD:1352880 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of COL6A1 mRNA CTD PMID:30165855 17beta-estradiol increases expression ISO RGD:1558231 6480464 Estradiol results in increased expression of COL6A1 mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO RGD:1352880 6480464 Estradiol results in increased expression of COL6A1 mRNA CTD PMID:23019147 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO RGD:1558231 6480464 Dihydrotestosterone results in decreased expression of COL6A1 mRNA CTD PMID:17023530 2,2,2-tetramine multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of COL6A1 protein] CTD PMID:19634143 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1558231 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COL6A1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of COL6A1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1558231 6480464 Tetrachlorodibenzodioxin affects the expression of COL6A1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1352880 6480464 Tetrachlorodibenzodioxin results in increased expression of COL6A1 mRNA CTD PMID:12377990 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1558231 6480464 Tetrachlorodibenzodioxin results in increased expression of COL6A1 mRNA CTD PMID:16120747 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of COL6A1 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1352880 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of COL6A1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COL6A1 mRNA CTD PMID:28628672 3-Nitrobenzanthrone affects expression ISO RGD:1352880 6480464 3-nitrobenzanthrone affects the expression of COL6A1 mRNA CTD PMID:34036453 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of COL6A1 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1558231 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of COL6A1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1352880 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of COL6A1 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of COL6A1 mRNA CTD PMID:28628672 , PMID:31601247 4,4'-sulfonyldiphenol increases expression ISO RGD:1352880 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of COL6A1 protein CTD PMID:34186270 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1352880 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of COL6A1 gene CTD PMID:31601247 4,4'-sulfonyldiphenol increases expression ISO RGD:1558231 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of COL6A1 mRNA CTD PMID:30951980 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of COL6A1 protein CTD PMID:23692979 4-hydroxyphenyl retinamide decreases expression ISO RGD:1558231 6480464 Fenretinide results in decreased expression of COL6A1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of COL6A1 mRNA CTD PMID:24780913 9-cis-retinoic acid decreases expression ISO RGD:1352880 6480464 Alitretinoin results in decreased expression of COL6A1 mRNA CTD PMID:15982314 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of COL6A1 mRNA CTD PMID:28959563 aldehydo-D-glucose affects secretion ISO RGD:1352880 6480464 Glucose deficiency affects the secretion of COL6A1 protein CTD PMID:24802182 all-trans-4-oxoretinoic acid decreases expression ISO RGD:1352880 6480464 4-oxoretinoic acid results in decreased expression of COL6A1 mRNA CTD PMID:15982314 all-trans-retinoic acid decreases expression ISO RGD:1352880 6480464 Tretinoin metabolite results in decreased expression of COL6A1 mRNA, Tretinoin results in decreased expression of COL6A1 mRNA CTD PMID:15982314 , PMID:33167477 all-trans-retinoic acid multiple interactions ISO RGD:1558231 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of COL6A1 mRNA CTD PMID:30951980 antirheumatic drug increases expression ISO RGD:1352880 6480464 Antirheumatic Agents results in increased expression of COL6A1 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1352880 6480464 aristolochic acid I results in increased expression of COL6A1 mRNA CTD PMID:33212167 atrazine increases expression ISO RGD:1352880 6480464 Atrazine results in increased expression of COL6A1 mRNA CTD PMID:22378314 azelastine decreases expression ISO RGD:1352880 6480464 azelastine results in decreased expression of COL6A1 mRNA CTD PMID:8919039 benzo[a]pyrene decreases expression ISO RGD:1558231 6480464 Benzo(a)pyrene results in decreased expression of COL6A1 mRNA CTD PMID:15034205 benzo[a]pyrene affects methylation ISO RGD:1352880 6480464 Benzo(a)pyrene affects the methylation of COL6A1 3' UTR, Benzo(a)pyrene affects the methylation of COL6A1 promoter CTD PMID:27901495 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of COL6A1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1352880 6480464 bisphenol A results in decreased expression of COL6A1 protein CTD PMID:34186270 bisphenol A decreases methylation ISO RGD:1352880 6480464 bisphenol A results in decreased methylation of COL6A1 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1558231 6480464 bisphenol A results in increased expression of COL6A1 mRNA CTD PMID:30951980 more ... bisphenol A multiple interactions ISO RGD:1352880 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COL6A1 mRNA CTD PMID:28628672 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of COL6A1 mRNA CTD PMID:30816183 more ... Bisphenol B increases expression ISO RGD:1352880 6480464 bisphenol B results in increased expression of COL6A1 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1558231 6480464 bisphenol F results in increased expression of COL6A1 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:1352880 6480464 bisphenol F results in increased expression of COL6A1 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:1558231 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of COL6A1 mRNA CTD PMID:30951980 cadmium atom multiple interactions ISO RGD:1352880 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COL6A1 mRNA CTD PMID:29741670 cadmium atom multiple interactions ISO RGD:1558231 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COL6A1 mRNA CTD PMID:36200916 cadmium dichloride multiple interactions ISO RGD:1558231 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COL6A1 mRNA, [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of COL6A1 mRNA CTD PMID:19840844 , PMID:36200916 cadmium dichloride multiple interactions ISO RGD:1352880 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COL6A1 mRNA CTD PMID:29741670 cadmium dichloride decreases expression ISO RGD:1558231 6480464 Cadmium Chloride results in decreased expression of COL6A1 mRNA CTD PMID:24982889 cadmium dichloride decreases expression ISO RGD:1352880 6480464 Cadmium Chloride results in decreased expression of COL6A1 protein CTD PMID:24527689 cantharidin decreases expression ISO RGD:1558231 6480464 Cantharidin results in decreased expression of COL6A1 mRNA CTD PMID:36907384 carbon nanotube multiple interactions ISO RGD:1558231 6480464 [Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in decreased expression of COL6A1 protein CTD PMID:34864091 carbon nanotube decreases expression ISO RGD:1558231 6480464 Nanotubes, Carbon results in decreased expression of COL6A1 protein CTD PMID:34864091 chlordecone increases expression ISO RGD:1558231 6480464 Chlordecone results in increased expression of COL6A1 mRNA CTD PMID:33711761 choline multiple interactions ISO RGD:1558231 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL6A1 mRNA CTD PMID:20548288 , PMID:20938992 chromium(6+) affects expression ISO RGD:1558231 6480464 chromium hexavalent ion affects the expression of COL6A1 mRNA CTD PMID:28472532 cisplatin multiple interactions ISO RGD:1352880 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of COL6A1 mRNA CTD PMID:27392435 copper atom multiple interactions ISO RGD:1352880 6480464 [Chelating Agents binds to Copper] which results in decreased expression of COL6A1 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1352880 6480464 [Chelating Agents binds to Copper] which results in decreased expression of COL6A1 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO RGD:1352880 6480464 Copper Sulfate results in increased expression of COL6A1 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1352880 6480464 Cyclosporine results in decreased expression of COL6A1 mRNA CTD PMID:20106945 D-glucose affects secretion ISO RGD:1352880 6480464 Glucose deficiency affects the secretion of COL6A1 protein CTD PMID:24802182 DDT increases expression EXP 6480464 DDT results in increased expression of COL6A1 mRNA CTD PMID:30207508 dexamethasone multiple interactions ISO RGD:1352880 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of COL6A1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COL6A1 mRNA CTD PMID:28628672 dextran sulfate decreases expression ISO RGD:1558231 6480464 Dextran Sulfate results in decreased expression of COL6A1 mRNA, Dextran Sulfate results in decreased expression of COL6A1 protein CTD PMID:32272095 , PMID:35093514 dextran sulfate multiple interactions ISO RGD:1558231 6480464 Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COL6A1 protein] CTD PMID:32272095 dibutyl phthalate decreases expression ISO RGD:1558231 6480464 Dibutyl Phthalate results in decreased expression of COL6A1 protein CTD PMID:34864091 dibutyl phthalate multiple interactions ISO RGD:1558231 6480464 [Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in decreased expression of COL6A1 protein CTD PMID:34864091 diethyl malate affects expression ISO RGD:1558231 6480464 diethyl malate affects the expression of COL6A1 mRNA CTD PMID:24814887 diuron decreases expression EXP 6480464 Diuron results in decreased expression of COL6A1 mRNA CTD PMID:25152437 diuron increases expression EXP 6480464 Diuron results in increased expression of COL6A1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1352880 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1558231 6480464 Doxorubicin results in increased expression of COL6A1 mRNA CTD PMID:15033991 doxorubicin affects expression ISO RGD:1352880 6480464 Doxorubicin affects the expression of COL6A1 mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO RGD:1558231 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of COL6A1 mRNA CTD PMID:21040762 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of COL6A1 mRNA CTD PMID:29391264 entinostat multiple interactions ISO RGD:1352880 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A1 mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:1352880 6480464 entinostat results in increased expression of COL6A1 mRNA CTD PMID:26272509 ethanol increases expression ISO RGD:1558231 6480464 Ethanol results in increased expression of COL6A1 mRNA CTD PMID:30319688 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of COL6A1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1558231 6480464 [1 more ... CTD PMID:20548288 more ... fulvestrant multiple interactions ISO RGD:1352880 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of COL6A1 gene CTD PMID:31601247 genistein increases expression ISO RGD:1352880 6480464 Genistein results in increased expression of COL6A1 mRNA CTD PMID:23019147 glucose affects secretion ISO RGD:1352880 6480464 Glucose deficiency affects the secretion of COL6A1 protein CTD PMID:24802182 indometacin multiple interactions ISO RGD:1352880 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of COL6A1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COL6A1 mRNA CTD PMID:28628672 inulin multiple interactions ISO RGD:1558231 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of COL6A1 mRNA CTD PMID:36331819 ionomycin multiple interactions ISO RGD:1352880 6480464 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of COL6A1 mRNA, pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of COL6A1 mRNA] CTD PMID:15477007 irinotecan increases expression ISO RGD:1352880 6480464 Irinotecan metabolite results in increased expression of COL6A1 mRNA, Irinotecan results in increased expression of COL6A1 mRNA CTD PMID:15956246 isotretinoin decreases expression ISO RGD:1352880 6480464 Isotretinoin results in decreased expression of COL6A1 mRNA CTD PMID:15982314 isotretinoin increases expression ISO RGD:1352880 6480464 Isotretinoin results in increased expression of COL6A1 mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:1352880 6480464 Ivermectin results in decreased expression of COL6A1 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1558231 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL6A1 mRNA CTD PMID:20548288 , PMID:20938992 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of COL6A1 mRNA CTD PMID:11578147 lipopolysaccharide decreases expression ISO RGD:1558231 6480464 Lipopolysaccharides results in decreased expression of COL6A1 mRNA CTD PMID:12057914 lipopolysaccharide increases expression ISO RGD:1558231 6480464 Lipopolysaccharides results in increased expression of COL6A1 mRNA CTD PMID:16977382 lipopolysaccharide multiple interactions ISO RGD:1558231 6480464 Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of COL6A1 mRNA] CTD PMID:16977382 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of COL6A1 mRNA CTD PMID:28801915 methotrexate affects expression ISO RGD:1558231 6480464 Methotrexate affects the expression of COL6A1 mRNA CTD PMID:18502557 methylparaben decreases expression ISO RGD:1352880 6480464 methylparaben results in decreased expression of COL6A1 mRNA CTD PMID:28382686 methylseleninic acid increases expression ISO RGD:1352880 6480464 methylselenic acid results in increased expression of COL6A1 mRNA CTD PMID:18548127 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:1558231 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of COL6A1 mRNA more ... CTD PMID:19840844 N-nitrosodiethylamine multiple interactions ISO RGD:1558231 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of COL6A1 mRNA] CTD PMID:17942915 N-nitrosodiethylamine increases expression ISO RGD:1558231 6480464 Diethylnitrosamine results in increased expression of COL6A1 mRNA CTD PMID:17942915 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of COL6A1 mRNA CTD PMID:24136188 nicotine multiple interactions ISO RGD:1558231 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of COL6A1 mRNA CTD PMID:24136188 ochratoxin A increases acetylation ISO RGD:1352880 6480464 ochratoxin A results in increased acetylation of COL6A1 promoter CTD PMID:29098329 ochratoxin A multiple interactions ISO RGD:1352880 6480464 [ochratoxin A results in increased acetylation of COL6A1 promoter] which results in increased expression of COL6A1 mRNA CTD PMID:29098329 ochratoxin A increases expression ISO RGD:1352880 6480464 ochratoxin A results in increased expression of COL6A1 mRNA CTD PMID:29098329 okadaic acid multiple interactions ISO RGD:1558231 6480464 [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of COL6A1 mRNA CTD PMID:19840844 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of COL6A1 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of COL6A1 mRNA CTD PMID:25729387 paclitaxel increases expression ISO RGD:1352880 6480464 Paclitaxel results in increased expression of COL6A1 mRNA CTD PMID:19682730 panobinostat increases expression ISO RGD:1352880 6480464 panobinostat results in increased expression of COL6A1 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1352880 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A1 mRNA CTD PMID:27188386 paraquat increases expression ISO RGD:1558231 6480464 Paraquat results in increased expression of COL6A1 mRNA CTD PMID:26345256 Pargyline multiple interactions ISO RGD:1558231 6480464 Pargyline inhibits the reaction [COL6A1 protein affects the abundance of Reactive Oxygen Species] CTD PMID:20716577 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1558231 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COL6A1 mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of COL6A1 mRNA CTD PMID:36331819 phenytoin decreases expression ISO RGD:1352880 6480464 Phenytoin results in decreased expression of COL6A1 mRNA CTD PMID:14741686 phenytoin increases expression ISO RGD:1352880 6480464 Phenytoin results in increased expression of COL6A1 mRNA CTD PMID:8224229 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1558231 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of COL6A1 mRNA CTD PMID:19840844 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1352880 6480464 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of COL6A1 mRNA, pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of COL6A1 mRNA] CTD PMID:15477007 potassium chromate multiple interactions ISO RGD:1352880 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of COL6A1 mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:1352880 6480464 potassium chromate(VI) results in increased expression of COL6A1 mRNA CTD PMID:22079256 potassium dichromate increases expression ISO RGD:1558231 6480464 Potassium Dichromate results in increased expression of COL6A1 mRNA CTD PMID:23608068 progesterone decreases expression ISO RGD:1352880 6480464 Progesterone results in decreased expression of COL6A1 mRNA CTD PMID:18070364 pyrrolidine dithiocarbamate multiple interactions ISO RGD:1352880 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of COL6A1 mRNA] CTD PMID:15477007 quercetin increases expression ISO RGD:1558231 6480464 Quercetin results in increased expression of COL6A1 mRNA CTD PMID:16455785 reactive oxygen species affects abundance ISO RGD:1558231 6480464 COL6A1 protein affects the abundance of Reactive Oxygen Species CTD PMID:20716577 reactive oxygen species multiple interactions ISO RGD:1558231 6480464 Pargyline inhibits the reaction [COL6A1 protein affects the abundance of Reactive Oxygen Species] CTD PMID:20716577 resveratrol affects secretion ISO RGD:1352880 6480464 resveratrol affects the secretion of COL6A1 protein CTD PMID:24802182 SB 431542 multiple interactions ISO RGD:1352880 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Se-methyl-L-selenocysteine increases expression ISO RGD:1352880 6480464 selenomethylselenocysteine results in increased expression of COL6A1 mRNA CTD PMID:18514395 Se-methylselenocysteine increases expression ISO RGD:1352880 6480464 selenomethylselenocysteine results in increased expression of COL6A1 mRNA CTD PMID:18514395 selenomethionine affects expression ISO RGD:1352880 6480464 Selenomethionine affects the expression of COL6A1 mRNA CTD PMID:17222674 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of COL6A1 mRNA CTD PMID:22431001 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of COL6A1 protein CTD PMID:29459688 sodium fluoride decreases expression ISO RGD:1558231 6480464 Sodium Fluoride results in decreased expression of COL6A1 protein CTD PMID:28918527 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of COL6A1 protein CTD PMID:19634143 streptozocin multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of COL6A1 protein] CTD PMID:19634143 sunitinib decreases expression ISO RGD:1352880 6480464 Sunitinib results in decreased expression of COL6A1 mRNA CTD PMID:31533062 Tanshinone I decreases expression ISO RGD:1352880 6480464 tanshinone results in decreased expression of COL6A1 mRNA CTD PMID:15849732 tert-butyl hydroperoxide increases expression ISO RGD:1352880 6480464 tert-Butylhydroperoxide results in increased expression of COL6A1 mRNA CTD PMID:15336504 testosterone increases expression ISO RGD:1558231 6480464 Testosterone results in increased expression of COL6A1 mRNA CTD PMID:19693291 testosterone enanthate affects expression ISO RGD:1352880 6480464 testosterone enanthate affects the expression of COL6A1 mRNA CTD PMID:17440010 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of COL6A1 mRNA CTD PMID:34492290 titanium dioxide affects expression ISO RGD:1558231 6480464 titanium dioxide affects the expression of COL6A1 mRNA CTD PMID:17656681 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of COL6A1 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of COL6A1 mRNA CTD PMID:25729387 topotecan affects response to substance ISO RGD:1352880 6480464 COL6A1 protein affects the susceptibility to Topotecan CTD PMID:16217747 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of COL6A1 mRNA CTD PMID:21683754 Tributyltin oxide increases expression ISO RGD:1558231 6480464 bis(tri-n-butyltin)oxide results in increased expression of COL6A1 mRNA CTD PMID:18958704 trichostatin A increases expression ISO RGD:1352880 6480464 trichostatin A results in increased expression of COL6A1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1352880 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A1 mRNA CTD PMID:27188386 urethane increases expression ISO RGD:1352880 6480464 Urethane results in increased expression of COL6A1 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1352880 6480464 Valproic Acid affects the expression of COL6A1 mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:1352880 6480464 Valproic Acid results in increased methylation of COL6A1 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1352880 6480464 Valproic Acid results in increased expression of COL6A1 mRNA CTD PMID:24935251 vancomycin decreases expression ISO RGD:1558231 6480464 Vancomycin results in decreased expression of COL6A1 mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of COL6A1 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of COL6A1 mRNA CTD PMID:23034163 Y-27632 multiple interactions ISO RGD:1352880 6480464 Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of COL6A1 mRNA] CTD PMID:30682444
